KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Operating Leases (2022 - 2025)

Historic Operating Leases for Co-Diagnostics (CODX) over the last 4 years, with Q3 2025 value amounting to $1.5 million.

  • Co-Diagnostics' Operating Leases fell 3785.58% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 3785.58%. This contributed to the annual value of $1.2 million for FY2024, which is 4254.38% down from last year.
  • Co-Diagnostics' Operating Leases amounted to $1.5 million in Q3 2025, which was down 3785.58% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Co-Diagnostics' Operating Leases registered a high of $3.2 million during Q2 2023, and its lowest value of $50708.0 during Q4 2022.
  • Its 4-year average for Operating Leases is $1.7 million, with a median of $1.7 million in 2025.
  • As far as peak fluctuations go, Co-Diagnostics' Operating Leases skyrocketed by 414426.13% in 2023, and later tumbled by 4254.38% in 2024.
  • Co-Diagnostics' Operating Leases (Quarter) stood at $50708.0 in 2022, then soared by 4144.26% to $2.2 million in 2023, then crashed by 42.54% to $1.2 million in 2024, then grew by 19.05% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $1.7 million for Q2 2025, and $1.9 million during Q1 2025.